iTRAQ-Based Proteomics Investigation of Aqueous Humor from Patients with Coats' Disease. [PDF]
PLoS ONE, 2016 Coats' disease is an uncommon form of retinal telangiectasis, and the identification of novel proteins that contribute to the development of Coats' disease is useful for improving treatment efficacy.
Qiong Yang +4 more
doaj +2 more sources
Coats′ disease of adult-onset in 48 eyes [PDF]
Indian Journal of Ophthalmology, 2016 Background: Coats′ disease diagnosed in adulthood is an idiopathic, retinal exudative vascular disease without an inciting factor and has retinal features different from the childhood disease.
Ekta Rishi +5 more
doaj +2 more sources
Clinical-histopathological correlation in a case of Coats' disease
Diagnostic Pathology, 2006 Background Coats' disease is a non-hereditary ocular disease, with no systemic manifestation, first described by Coats in 1908. It occurs more commonly in children and has a clear male predominance.
Zajdenweber Moyses E +5 more
doaj +3 more sources
Vitrectomy for epiretinal membrane in adult-onset Coats' disease
Indian Journal of Ophthalmology, 2017 Coats' disease is characterized by retinal vascular telangiectasia and subretinal and intraretinal exudation. A relatively benign form of the disease that occurs in adults is referred to as adult-onset Coats' disease. Involvement of macula in the form of
Pradeep Kumar, Vinod Kumar
doaj +2 more sources
Adult onset coats disease in a 56-year-old male: An atypical presentation
Medical Journal of Dr. D.Y. Patil University, 2015 Coats disease is a congenital retinal vascular disease, which is seen commonly in childhood and remits and exacerbates throughout life. However, it is not rare for coats disease to present in adulthood for the first time.
Bodhraj Dhawan +3 more
doaj +2 more sources
Rapid “epiretinal membrane” development following intravitreal bevacizumab for Coats' disease
American Journal of Ophthalmology Case Reports, 2018 Purpose: To report a case of rapid “epiretinal membrane” (“ERM”) development following intravitreal bevacizumab for juvenile Coats' disease. Observations: A 7-year old boy was followed for four years with asymptomatic stage 2 Coats' disease in his left ...
Andrew W. Kam +3 more
doaj +2 more sources
Serum hypercoagulability states in Coats’ disease
Clinical Ophthalmology, 2017 Fariba Ghassemi,1 Carol L Shields,2 Masoumeh Mohebbi,1 Mehdi Nili Ahmadabadi,1 Fatemeh Morsali,1 Siamak Sabour3,4 1Ocular Oncology and Retina and Vitreous Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran; 2Ocular ...
Ghassemi F +5 more
doaj +1 more source
Coats disease in adolescence and adulthood with preserved vision after laser photocoagulation monotherapy: two case reports [PDF]
Journal of Medical Case Reports, 2022 Background This case report describes two rare cases of Coats disease in nonjuvenile patients with preserved vision. Case presentation Two otherwise healthy Asian males aged 15 and 29 years old presented with unilateral gradual blurred vision and scotoma,
Gitalisa Andayani Adriono +2 more
doaj +2 more sources
Over 10 years follow-up of Coats' disease in adulthood
Clinical Ophthalmology, 2011 Tatsuro Otani1, Kanako Yasuda1, Naoko Aizawa2, Fumiaki Sakai3, Toru Nakazawa2, Masahiko Shimura11Department of Ophthalmology, NTT East Japan Tohoku Hospital, 2Department of Ophthalmology, Tohoku University School of Medicine, 3Heisei Ophthalmic ...
Otani T +5 more
doaj +1 more source
Dexamethasone intravitreal implant as an adjuvant treatment for pediatric patients with Coats' disease. [PDF]
Arq Bras Oftalmol, 2023 We report two cases of stage 3A unilateral Coats’ disease in pediatric patients. In both cases, disease control was achieved using a dexamethasone intravitreal implant in addition to other treatments.
Dorado AM +4 more
europepmc +2 more sources